When vaccinated with ovalbumin (OVA), licorice root extract-derived nanoparticles (Glycyrrhiza-NPs) can activate antigen-specific CD8+ T lymphocytes and trigger the release of IFN-γ, which has a significant anti-tumor effect. This evidence concerns the gene CD8A and neoplasm.